Collgard Biopharmaceuticals' Series B Round

Collgard Biopharmaceuticals raised a round of funding on August 01, 2002.

Collgard Biopharmaceuticals develops products for tissue modulation involving collagen economy targeted at Vascular restenosis end-organ fibrosis selected cancer and dermal fibroproliferative disorder…

Articles about Collgard Biopharmaceuticals' Series B Round: